| [9] |
Buchbinder M，Solar R.Targeted vascular drug delivery.A new day for an old way[J].Panminerva Med，2013，55（4）：353-361.
|
| [1] |
ZhuM，YangM，LinJ，etal.Associationofsevenreninangiotensin system gene polymorphisms with restenosis in patients following coronary stenting[J].J Renin-Angiotensin-Aldost Sy，2017，18（1）：1-9.
|
| [2] |
Bassous N，Cooke JP，Webster TJ.Enhancing Stent Effectiveness with Nanofeatures[J].Methodist Debakey Cardiovasc J，2016，12（3）：163-168.
|
| [3] |
Kim YH，Lee JH，Roh JH，et al.Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis[J].Jacc Cardiovasc Interv，2015，8（4）：550-560.
|
| [4] |
Sotomi Y，Onuma Y，Collet C，et al.Bioresorbable scaffold：the emerging reality and future directions[J].Circ Res，2017，120（8）：1341-1352.
|
| [5] |
Alt E，Haehnel I，Beilharz C，et al.Inhibition of neointima formation after experimental coronary artery stenting：a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost[J].Circulation，2000，101（12）：1453-1458.
|
| [6] |
Ancona MB，Tanaka A，Latib A，et al.Restored physiological vasomotion imitating intrascaffold restenosis 3 years after bioresorbable scaffold implantation[J].Can J Cardiol Home，2016，32（12）：e9-e10.
|
| [7] |
Murata N，Takayama T，Hiro T.Serial observations of instent restenosis treated with drug-coated balloon angioplasty by optical coherence tomography and coronary angioscopy[J]. Int Heart J，2017，58（1）：134-139.
|
| [8] |
Roubin GS，Gruentzig AR.Percutaneous transluminal coronary angioplasty：state of the art and future directions[J].Int J Cardiac Imaging，1985，1（2）：143-154.
|
| [10] |
Kalra A，Rehman H，Khera S，et al.New-Generation coronary stents：current data and future directions[J].Curr Atheroscler Rep，2017，19（3）：14.
|
| [11] |
Codner P，Gurm HS，Motivala A.Coronary stents in diabetic patients：state of the knowledge[J].Curr Cardiol Rep，2017，19（4）：28.
|
| [12] |
Jinnouchi H，Kuramitsu S，Shinozaki T，et al.Difference of tissue characteristics between early and late restenosis after second-generation drug-eluting stents implantation-an optical coherence tomography study[J].Circ J，2017，81（4）：450-457.
|
| [13] |
Burzotta F，Leone AM，Demaria GL，et al.Fractional flow reserve or optical coherence tomography guidance to revascularize intermediate coronary stenosis using angioplasty（FORZA）trial：study protocol for a randomized controlled trial[J].Trials，2014，15（1）：1-9.
|
| [14] |
Malik N，Banning AS，Belger M，et al.A risk scoring system to predict coronary stent thrombosis[J].Curr Med Res Opin，2017，33（5）：859-867.
|
| [15] |
Gabbasov Z，Kozlov S，Byazrova S，et al.Blood level of CD45+platelets and development of restenosis after drugeluting stent implantation in patients with stable coronary artery disease[J].Wien Klin Wochenschr，2016，128（23-24）：898-905.
|
| [16] |
Shah P，Vasudev R，Abuarqoub AH，et al.Cocaine-induced very late stent thrombosis[J].BMJ Case Reports，2016：2016. [17]Hsieh MJ，Huang YC，Yeh JK，et al.Predictors of longterm outcomes after drug-eluting balloon angioplasty for bare-metal stent restenosis[J].Heart，lung circ，2017.
|
| [18] |
Kang YH，Lao HY，Yu XY，et al.Progress in genetic and epigenetic research on in-stent restenosis after percutaneous coronary interventions[J].Chin J Med Genet，2012，29（1）：38-42.
|
